Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Gordon

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drugs - Real World Outcomes|March 8, 2020
Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort StudyBonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, et al.
Pulmonary Circulation|March 19, 2021
A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinilDiane L Zwicke, Ricardo Restrepo-Jaramillo, Hassan Alnuaimat, et al.
Suicide & Life-Threatening Behavior|July 10, 2024
Communicating the science of suicide prevention: A call to action for psychologistsAllison E Bond, Taylor R Rodriguez, Shelby L Bandel, et al.
JCO Oncology Practice|August 28, 2020
Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General OncologyFiona Kennedy, Kate Absolom, Beverly Clayton, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
Annals of the American Thoracic Society|March 14, 2019
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims AlgorithmsStephen C Mathai, Anna Ryan Hemnes, Scott Manaker, et al.
Clinical Trials (London, England)|October 27, 2025
Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility studyLeanne Shearsmith, Sarah Danson, Sarah Gelcich, et al.
BJS Open|November 23, 2022
Recruiting to surgical trials in the emergency setting: using a mixed methods study to understand clinician and patient perspectivesMaureen Twiddy, Jacqueline Birtwistle, Amanda Edmondson, et al.
Advances in Therapy|May 15, 2026
Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment ComparisonsBradley P Dixon, Andrew S Bomback, Carly Rich, et al.
Pulmonary Circulation|July 11, 2019
EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokineticsR James White, Keyur Parikh, Roblee Allen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drugs - Real World Outcomes|March 8, 2020
Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort StudyBonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, et al.
Pulmonary Circulation|March 19, 2021
A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinilDiane L Zwicke, Ricardo Restrepo-Jaramillo, Hassan Alnuaimat, et al.
Suicide & Life-Threatening Behavior|July 10, 2024
Communicating the science of suicide prevention: A call to action for psychologistsAllison E Bond, Taylor R Rodriguez, Shelby L Bandel, et al.
JCO Oncology Practice|August 28, 2020
Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General OncologyFiona Kennedy, Kate Absolom, Beverly Clayton, et al.
Kidney360|December 8, 2025
Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GlomerulonephritisFernando Caravaca-Fontan, Sayna Norouzi, Mingyi Huang, et al.
Annals of the American Thoracic Society|March 14, 2019
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims AlgorithmsStephen C Mathai, Anna Ryan Hemnes, Scott Manaker, et al.
Clinical Trials (London, England)|October 27, 2025
Electronic patient-reported adverse event monitoring in academic early-phase clinical trials: A feasibility studyLeanne Shearsmith, Sarah Danson, Sarah Gelcich, et al.
BJS Open|November 23, 2022
Recruiting to surgical trials in the emergency setting: using a mixed methods study to understand clinician and patient perspectivesMaureen Twiddy, Jacqueline Birtwistle, Amanda Edmondson, et al.
Advances in Therapy|May 15, 2026
Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment ComparisonsBradley P Dixon, Andrew S Bomback, Carly Rich, et al.
Pulmonary Circulation|July 11, 2019
EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokineticsR James White, Keyur Parikh, Roblee Allen, et al.
Pageof 3